Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
Trial · NCT00383123
Results by group138
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 138
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | A/New Caledonia [6 to <36 months] | 52.4 | 95% Confidence Interval 43.3 to 63.4 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | A/New Caledonia [6 to <36 months] | 101.4 | 95% Confidence Interval 86.9 to 118.2 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | A/Wisconsin [6 to <36 months] | 80.5 | 95% Confidence Interval 62.2 to 104.1 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | A/Wisconsin [6 to <36 months] | 218.0 | 95% Confidence Interval 185.8 to 255.8 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | B/Malaysia [6 to <36 months] | 20.2 | 95% Confidence Interval 15.9 to 25.8 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | B/Malaysia [6 to <36 months] | 40.6 | 95% Confidence Interval 32.3 to 51.1 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | A/New Caledonia [3 to < 5 years] | 130.3 | 95% Confidence Interval 108.6 to 156.4 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | A/New Caledonia [3 to < 5 years] | 168.7 | 95% Confidence Interval 138.7 to 205.2 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | A/Wisconsin [3 to < 5 years] | 458.1 | 95% Confidence Interval 365.3 to 574.3 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | A/Wisconsin [3 to < 5 years] | 483.4 | 95% Confidence Interval 396.8 to 588.9 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluarix Group | B/Malaysia [3 to < 5 years] | 54.9 | 95% Confidence Interval 42.3 to 71.1 | Titer |
| Geometric Mean Titer (GMT) of Serum Haemagglutination-inhibition (HI) Antibodies | Fluzone Group | B/Malaysia [3 to < 5 years] | 64.4 | 95% Confidence Interval 49.5 to 83.8 | Titer |
| Number of Seroconverted Subjects | Fluarix Group | A/New Caledonia [6 to <36 months] | 105 | Participants | |
| Number of Seroconverted Subjects | Fluzone Group | A/New Caledonia [6 to <36 months] | 179 | Participants | |
| Number of Seroconverted Subjects | Fluarix Group | A/Wisconsin [6 to <36 months] | 117 | Participants | |
| Number of Seroconverted Subjects | Fluzone Group | A/Wisconsin [6 to <36 months] | 190 | Participants | |
| Number of Seroconverted Subjects | Fluarix Group | B/Malaysia [6 to <36 months] | 48 | Participants | |
| Number of Seroconverted Subjects | Fluzone Group | B/Malaysia [6 to <36 months] | 114 | Participants | |
| Number of Seroconverted Subjects | Fluarix Group | A/New Caledonia [3 to <5 years] | 160 | Participants | |
| Number of Seroconverted Subjects | Fluzone Group | A/New Caledonia [3 to <5 years] | 159 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00383123/results